Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimal Tube Feeding Method in Head and Neck Cancer Patients

NCT: NCT01536782 · WITHDRAWN

NCT IDNCT01536782
StatusWITHDRAWN
Start Date2015-02
Completion2017-02

Brief Summary

The purpose of this study is to assess the optimal tube feeding method (bolus, gravity or pump) by analyzing percent weight loss, tolerance of enteral feeds, and percent of estimated calorie and protein needs in 60 patients with squamous cell carcinoma of the head and neck undergoing chemoradiation therapy.

Frequently Asked Questions

What is Optimal Tube Feeding Method in Head and Neck Cancer Patients?

Optimal Tube Feeding Method in Head and Neck Cancer Patients is a clinical trial registered under NCT01536782. Current status: WITHDRAWN.

What is the status of NCT01536782?

The current status of NCT01536782 (Optimal Tube Feeding Method in Head and Neck Cancer Patients) is: WITHDRAWN.

When did Optimal Tube Feeding Method in Head and Neck Cancer Patients start?

Optimal Tube Feeding Method in Head and Neck Cancer Patients started on 2015-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.